Drugs / OT-730
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00753168 | Sep → Dec 2008 | ocular hypertension, open-angle glaucoma | Othera Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OT-730 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00753168 ↗ |
| Action | Inhibit | “an active beta blocker” NCT00753168 ↗ |
| Route | Topical | “when applied as an eyedrop” NCT00753168 ↗ |